BIG PHARMA WATCH: MERCK PLOTS TO FURTHER BLOCK COMPETITION AND EXTEND MONOPOLY PRICING ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Dec 2, 2022
Big Pharma Giant Wants New Patents for Formulation Changes That Won’t… Read More
© 2026 CSRXP- All Rights Reserved
Big Pharma Watch
BIG PHARMA WATCH: DRUG COMPANY VERTEX PRICE-GOUGING BRAND NAME CYSTIC FIBROSIS TREATMENTS AND BANKING HUGE PROFITS
Nov 30, 2022
Patient Advocates Warn Access to Egregiously Priced Treatments at Risk Drug… Read More
BIG PHARMA WATCH: REPRESENTATIVE KATIE PORTER HIGHLIGHTS BIG PHARMA’S OUTRAGEOUS CANCER DRUG LAUNCH PRICES
Nov 3, 2022
New Report Finds Brand Name Drug Companies Increased Prices on New Oncology… Read More
BIG PHARMA WATCH: DRUG MAKER PRICES CHEMO TREATMENT TEN TIMES ABOVE THE MARKET AS PATIENTS FACE SHORTAGES
Oct 28, 2022
Areva Pharmaceuticals Price-Gouges Cancer Patients Who Rely on Older Oncology… Read More
BIG PHARMA WATCH: BIG PHARMA’S EGREGIOUS PRICING PRACTICES FORCE MORE THAN ONE MILLION AMERICANS TO RATION INSULIN DUE TO COST
Oct 20, 2022
The Problem with Insulin Affordability is the Price, Driven by “Shadow… Read More
BIG PHARMA WATCH: BIG PHARMA HIKED PRICES FASTER THAN INFLATION ON MORE THAN 1,200 DRUGS FROM 2021-2022
Oct 4, 2022
HHS Reports Demonstrate Cost of Big Pharma Egregious Pricing Practices and… Read More
BIG PHARMA WATCH: BIOGEN TO PAY U.S. GOVERNMENT $900M FOR ANTI-COMPETITIVE KICKBACK SCHEME
Sep 27, 2022
Biogen Agrees to Settle Case Over Illegally Paying Doctors to Push Brand Name… Read More
BIG PHARMA WATCH: CEO UNDERCUTS OWN INDUSTRY’S DOOM AND GLOOM RHETORIC ON RECENT DRUG PRICING SOLUTIONS
Sep 22, 2022
Novartis Exec Calls Policy to Keep Price Hikes Below Inflation… Read More
BIG PHARMA WATCH: REPORT FINDS BIG PHARMA’S “PERVASIVE” PATENT ABUSE “THE ROOT OF THE DRUG PRICING CRISIS”
Sep 15, 2022
I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will… Read More
BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY
Sep 9, 2022
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance… Read More
BIG PHARMA WATCH: DRUG COMPANIES ON PACE FOR RECORD 2022 LAUNCH PRICES
Aug 16, 2022
Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with… Read More
BIG PHARMA WATCH: ABBVIE UTILIZED LOOPHOLES TO AVOID PAYING BILLIONS IN U.S. TAXES & FURTHER MAXIMIZE PROFITS WHILE HIKING PRICES
Jul 8, 2022
Committee Report Shows How Brand Name Drug Company Further Juiced Profits on… Read More